PetMed Express Valuation
| PETS Stock | USD 3.46 0.15 4.53% |
At this time, the company appears to be fairly valued. PetMed Express holds a recent Real Value of $3.32 per share. The prevailing price of the company is $3.46. Our model determines the value of PetMed Express from analyzing the company fundamentals such as Operating Margin of (0.01) %, return on equity of 0.0036, and Shares Outstanding of 20.66 M as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting PetMed Express' valuation include:
Price Book 0.7109 | Enterprise Value | Enterprise Value Ebitda 2.5796 | Price Sales 0.2768 | Forward PE 17.9211 |
Fairly Valued
Today
Please note that PetMed Express' price fluctuation is relatively risky at this time. Calculation of the real value of PetMed Express is based on 3 months time horizon. Increasing PetMed Express' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the PetMed stock is determined by what a typical buyer is willing to pay for full or partial control of PetMed Express. Since PetMed Express is currently traded on the exchange, buyers and sellers on that exchange determine the market value of PetMed Stock. However, PetMed Express' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 3.46 | Real 3.32 | Target 3.6 | Hype 3.48 | Naive 3.4 |
The intrinsic value of PetMed Express' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence PetMed Express' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of PetMed Express helps investors to forecast how PetMed stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of PetMed Express more accurately as focusing exclusively on PetMed Express' fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use PetMed Express' intrinsic value based on its ongoing forecasts of PetMed Express' financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against PetMed Express' closest peers.
PetMed Express Cash |
|
PetMed Valuation Trend
PetMed Express' real value is important for investors to make better decisions and a more accurate overall view of PetMed Express' financial worth over time. Using both PetMed Express' enterprise value as well as its market capitalization is the best way to gauge the value of the company and is usually enough for investors to make market timing conclusions.
PetMed Express Total Value Analysis
PetMed Express is at this time anticipated to have valuation of 19.39 M with market capitalization of 68.37 M, debt of 1.45 M, and cash on hands of 105.41 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the PetMed Express fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
19.39 M | 68.37 M | 1.45 M | 105.41 M |
PetMed Express Investor Information
About 29.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 0.71. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. PetMed Express has Price/Earnings To Growth (PEG) ratio of 2.58. The entity last dividend was issued on the 11th of August 2023. The firm had 959692:319897 split on the 4th of March 1999. Based on the key indicators related to PetMed Express' liquidity, profitability, solvency, and operating efficiency, PetMed Express is not in a good financial situation at the moment. It has a very high risk of going through financial straits in August.PetMed Express Asset Utilization
The concept of asset utilization usually refers to the revenue earned for every dollar of assets a company currently reports. The newest return on assets of PetMed implies not a very effective usage of assets in July.PetMed Express Ownership Allocation
PetMed Express owns a total of 20.66 Million outstanding shares. PetMed Express has significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.PetMed Express Profitability Analysis
The company reported the previous year's revenue of 281.06 M. Net Loss for the year was (7.46 M) with profit before overhead, payroll, taxes, and interest of 68.37 M.PetMed Express Past Distributions to stockholders
About PetMed Express Valuation
The stock valuation mechanism determines PetMed Express' current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of PetMed Express based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of PetMed Express. We calculate exposure to PetMed Express's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of PetMed Express's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 90.4 M | 72.2 M | |
| Pretax Profit Margin | (0.02) | (0.02) | |
| Operating Profit Margin | (0.03) | (0.02) | |
| Net Loss | (0.02) | (0.02) | |
| Gross Profit Margin | 0.32 | 0.39 |
A single share of PetMed Express represents a small ownership stake in the entity. As a stockholder of PetMed, your percentage of company ownership is determined by dividing the number of shares you own by the total number of shares outstanding and then multiplying that amount by 100. Owning stock in a company generally confers both corporate voting rights and income from any dividends paid to the stock owner.
PetMed Express Dividends Analysis For Valuation
Please note that PetMed Express has scaled down on payment of dividends at this time. Retained Earnings is likely to drop to about 72 M in 2025. Retained Earnings Total Equity is likely to drop to about 107.8 M in 2025
There are various types of dividends PetMed Express can pay to its shareholders, and the actual value of the dividend is determined on a per-share basis. It is to be paid equally to all of PetMed shareholders on a specific date, known as the payable date. The cash dividend is the most common type of dividend payment - it is the payment of actual cash from PetMed Express directly to its shareholders. There are other types of dividends that companies can issue, such as stock dividends or asset dividends. When PetMed pays a dividend, it has no impact on its enterprise value. It does, however, lowers the Equity Value of PetMed Express by the value of the dividends paid out.
PetMed Express Growth Indicators
Investing in growth stocks can be very risky. If the company such as PetMed Express does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 20.4 M | |
| Quarterly Earnings Growth Y O Y | 2.667 | |
| Forward Price Earnings | 17.9211 |
PetMed Express Current Valuation Indicators
PetMed Express' valuation analysis is a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final PetMed Express' valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as PetMed Express, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use PetMed Express' valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes PetMed Express' worth.Additional Tools for PetMed Stock Analysis
When running PetMed Express' price analysis, check to measure PetMed Express' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy PetMed Express is operating at the current time. Most of PetMed Express' value examination focuses on studying past and present price action to predict the probability of PetMed Express' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move PetMed Express' price. Additionally, you may evaluate how the addition of PetMed Express to your portfolios can decrease your overall portfolio volatility.